Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
The Journal of Urology|December 9, 2025
Treatment of High-Risk Biochemically Recurrent Prostate Cancer With Enzalutamide in Combination With Leuprolide: Secondary Endpoints From the EMBARK TrialNeal D Shore, Martin Gleave, Ugo De Giorgi, et al.Urologic Oncology|May 4, 2020
A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population-The MiCheck-01 prospective trialNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.British Journal of Cancer|November 11, 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTANJohn Shen, Simon Chowdhury, Neeraj Agarwal, et al.The New England Journal of Medicine|October 18, 2023
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate CancerStephen J Freedland, Murilo de Almeida Luz, Ugo De Giorgi, et al.The New England Journal of Medicine|October 22, 2025
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate CancerNeal D Shore, Murilo de Almeida Luz, Ugo De Giorgi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2025
TAR-200 for Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: Results From the Phase IIb SunRISe-1 StudySiamak Daneshmand, Michiel S Van der Heijden, Joseph M Jacob, et al.Prostate Cancer and Prostatic Diseases|November 2, 2025
DARolutamide ObservationaL (DAROL) study in patients with nonmetastatic castration-resistant prostate cancer: prespecified third interim analysisEvan Y Yu, Hiroyoshi Suzuki, Christopher M Pieczonka, et al.Urologic Oncology|September 21, 2023
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancerNeal D Shore, Dmitry M Polikarpov, Christopher M Pieczonka, et al.Current Opinion in Urology|October 9, 2025
Side effect management and procedural best practices with indwelling intravesical drug-releasing systems in the treatment of bladder cancer: recommendations from expert panelsBenjamin Pradere, Maarten Schuit, Félix Guerrero-Ramos, et al.Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.Pageof 3